MVA newsletter no 12, November 2003
: NEWS INDEX
MVA press release: Regional research program creates public/private collaborations
Biostatistics conference: Analysis of ordinal data - a practical approach
Medicon Valley Academy expands in Sweden
Canadian biotech companies to choose Medicon Valley
Osteoporosis treatment drug on the way
DKK 40 million to T-cellic cancer treatment development
Medicon A/S initiates a new clinical research unit
Pharmexa and Bavarian Nordic join forces against breast cancer
: MVA NEWS
MVA press release: Regional research program creates
public/private collaborations
DKK 9 million from the Greater Copenhagen Authority (HUR) made
it possible to educate 12 new researchers within the
medico, health and biotech area.
More Information... (Danish)
www.mva.org/composite-821.htm
Biostatistics conference: Analysis of ordinal data
- a practical approach
2-4 December 2003 / Ideon
/ Lund / Sweden
Arranged by Medicon Valley Academy and the "Biostatistics in
Øresund" network.
More Information... (English)
www.mva.org/composite-583.htm
Medicon Valley Academy expands in
Sweden
Stina Gestrelius, Vice President R&D
at Biora AB in Malmö, will join Medicon Valley Academy 1
January 2004.
More Information... (Swedish)
www.mva.org/composite-806.htm
: MEDICON VALLEY NEWS
Canadian biotech companies to choose Medicon
Valley
After having focused its biotech efforts on
USA for several years, Copenhagen Capacity now turns further to the
north into Canada to launch a drive for Medicon Valley.
More Information... (English)
www.mva.org/composite-807.htm
Osteoporosis treatment drug on the
way
Positive Phase II trials of an osteoporosis
treatment drug from Gramineer International AB has been
concluded.
More Information... (Danish)
www.mva.org/composite-793.htm
DKK 40 million to T-cellic cancer
treatment development
T-cellic's second
financing round gave DKK 40 million mainly from Lønmodtagernes
Dyrtidsfond, Scandinavian Life Science Venture and The Danish
Investment Fund. The investment will make it possible for
T-cellic to reach the clinical phase trials of
their cancer treatment development.
More Information... (Danish)
www.mva.org/composite-787.htm
Medicon A/S initiates a new clinical research
unit
In January 2004 Medicon A/S initiates a new
activity: Medicon Clinical Pharmacology - a dedicated clinical
research unit providing full clinical services for volunteer and
patient studies.
More Information... (English)
www.mva.org/composite-789.htm
Pharmexa and Bavarian Nordic join forces against
breast cancer
Development of a breast cancer vaccine
is the goal of a new Pharmexa and Bavarian
Nordic collaboration. The vaccine combines Bavarian
Nordic’s MVA-BN vector technology and Pharmexa’s HER-2 DNA AutoVac™
vaccine. Clinical trials could start within 18 months in Germany
and Italy.
More Information... (English)
www.mva.org/composite-781.htm
: EVENTS
Research, Information and Region Growth - a
conflict?
20-21 November 2003 / Malmö /
Sweden
A seminar on challenges and possibilities of information transfer
in the perspective of a fast developing high
technological research.
More Information... (Danish) www.mva.org/composite-790.htm
CBS Research Results on Øresund Region
Development
26 November 2003 / CBS / Copenhagen
/ Danmark
A seminar concerning results from the Danish/Swedish Øresund Region
Research Program "Der findes grænser".
More Information... (Danish)
www.mva.org/composite-795.htm
Human Embryonic Stem Cell Symposium
2
December 2003 / Hagedorn Research Institute / Copenhagen /
Denmark
"Brave New Medicine" is a symposium hosted by the British Embassy
in Denmark. Prominent British researchers are invited to
speak.
More Information... (English)
www.mva.org/composite-805.htm
Cordia EuropaBio Convention 2003
2-4 December
2003 / Vienna / Austria
The Cordia conference is designed to disseminate the latest
knowledge on harmonisation and integration within the biotech
industry, and foster debate with policy makers.
More Information... (English)
www.mva.org/composite-536.htm
The 2nd Swedish Proteomics Society Symposium
2003
7-8 December / Scandic Hotel Star / Lund /
Sweden
The Swedish Proteomics Society is proud to announce the second
national Symposium covering the protein expression profiling
research area.
More Information... (English)
www.mva.org/composite-794.htm
6th Biotech & Finance Forum
16-17
December 2003 / Barcelona / Spain / Reduced price for MVA
members: 10% reduction
The Biotech & Finance Forum is an exclusive summit of the
leading individuals and organisations who are the driving forces
behind bio-entrepreneurship & businesses in Europe.
More Information... (English)
www.mva.org/composite-768.htm